Cecilia Furlong
Stock Analyst at Morgan Stanley
(1.83)
# 3,120
Out of 4,876 analysts
170
Total ratings
43.66%
Success rate
-1.91%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Cecilia Furlong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IRTC iRhythm Technologies | Maintains: Overweight | $130 → $160 | $154.71 | +3.42% | 16 | Jun 11, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Equal-Weight | $115 → $95 | $91.46 | +3.87% | 12 | May 6, 2025 | |
| ISRG Intuitive Surgical | Upgrades: Overweight | $522 → $650 | $533.71 | +21.79% | 13 | Dec 2, 2024 | |
| SGHT Sight Sciences | Maintains: Equal-Weight | $7 → $5 | $4.30 | +16.28% | 15 | Nov 11, 2024 | |
| EMBC Embecta | Maintains: Underweight | $13 → $12 | $9.64 | +24.48% | 12 | Jul 15, 2024 | |
| TMDX TransMedics Group | Maintains: Equal-Weight | $75 → $95 | $131.45 | -27.73% | 12 | Feb 28, 2024 | |
| MDT Medtronic | Maintains: Overweight | $104 → $98 | $86.02 | +13.93% | 9 | Nov 22, 2023 | |
| ALC Alcon | Maintains: Equal-Weight | $78 → $85 | $87.81 | -3.20% | 9 | May 11, 2023 | |
| AORT Artivion | Maintains: Equal-Weight | $14 → $15 | $31.19 | -51.91% | 4 | May 8, 2023 | |
| PODD Insulet | Maintains: Equal-Weight | $325 → $343 | $313.08 | +9.56% | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $11 → $14 | $2.60 | +438.46% | 7 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $44 → $48 | $30.39 | +57.95% | 4 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $95 → $102 | $78.21 | +30.42% | 8 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $56 → $58 | $106.53 | -45.56% | 17 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $18 → $20 | $12.40 | +61.29% | 5 | Feb 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $117 → $131 | $86.33 | +51.74% | 7 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $117 → $133 | $134.38 | -1.03% | 11 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $270 → $220 | $393.55 | -44.10% | 4 | Jul 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $383 → $378 | $119.47 | +216.40% | 2 | Feb 25, 2022 |
iRhythm Technologies
Jun 11, 2025
Maintains: Overweight
Price Target: $130 → $160
Current: $154.71
Upside: +3.42%
Zimmer Biomet Holdings
May 6, 2025
Maintains: Equal-Weight
Price Target: $115 → $95
Current: $91.46
Upside: +3.87%
Intuitive Surgical
Dec 2, 2024
Upgrades: Overweight
Price Target: $522 → $650
Current: $533.71
Upside: +21.79%
Sight Sciences
Nov 11, 2024
Maintains: Equal-Weight
Price Target: $7 → $5
Current: $4.30
Upside: +16.28%
Embecta
Jul 15, 2024
Maintains: Underweight
Price Target: $13 → $12
Current: $9.64
Upside: +24.48%
TransMedics Group
Feb 28, 2024
Maintains: Equal-Weight
Price Target: $75 → $95
Current: $131.45
Upside: -27.73%
Medtronic
Nov 22, 2023
Maintains: Overweight
Price Target: $104 → $98
Current: $86.02
Upside: +13.93%
Alcon
May 11, 2023
Maintains: Equal-Weight
Price Target: $78 → $85
Current: $87.81
Upside: -3.20%
Artivion
May 8, 2023
Maintains: Equal-Weight
Price Target: $14 → $15
Current: $31.19
Upside: -51.91%
Insulet
May 5, 2023
Maintains: Equal-Weight
Price Target: $325 → $343
Current: $313.08
Upside: +9.56%
May 3, 2023
Maintains: Equal-Weight
Price Target: $11 → $14
Current: $2.60
Upside: +438.46%
Apr 28, 2023
Maintains: Equal-Weight
Price Target: $44 → $48
Current: $30.39
Upside: +57.95%
Apr 27, 2023
Maintains: Overweight
Price Target: $95 → $102
Current: $78.21
Upside: +30.42%
Apr 27, 2023
Maintains: Overweight
Price Target: $56 → $58
Current: $106.53
Upside: -45.56%
Feb 23, 2023
Maintains: Equal-Weight
Price Target: $18 → $20
Current: $12.40
Upside: +61.29%
Jan 6, 2023
Maintains: Equal-Weight
Price Target: $117 → $131
Current: $86.33
Upside: +51.74%
Jan 6, 2023
Maintains: Overweight
Price Target: $117 → $133
Current: $134.38
Upside: -1.03%
Jul 15, 2022
Maintains: Equal-Weight
Price Target: $270 → $220
Current: $393.55
Upside: -44.10%
Feb 25, 2022
Maintains: Equal-Weight
Price Target: $383 → $378
Current: $119.47
Upside: +216.40%